Status
Conditions
Treatments
About
The study was designed to analyze the efficacy and safety of Paxlovid for the treatment of COVID-19.
Full description
The study is a real-world study and the case records of patients with COVID-19 who visit Huashan Hospital affiliated to Fudan University from 2022 to 2027 and receive Paxlovid therapy will be collected in this study. The medical data including patient demographic, clinical characteristics, laboratory examination, history of treatments, adverse reactions and treatment outcome will be extracted to analyze the effectivity and safety of paxlovid and explore the prognosis-relevant factors of COVID-19.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
2,000 participants in 2 patient groups
Loading...
Central trial contact
Feng Sun, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal